Brivudine NEW
| Price | $55 | $72 | $98 |
| Package | 50mg | 100mg | 200mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-04-27 |
Product Details
| Product Name: Brivudine | CAS No.: 69304-47-8 |
| Purity: 99.85% | Supply Ability: 10g |
| Release date: 2025/04/27 |
Product Introduction
Bioactivity
| Name | Brivudine |
| Description | Brivudine (BVDU), an antiviral medicine, is used in the therapy of herpes zoster. |
| In vitro | Brivudine is an analog of thymidine, and is incorporated into the viral DNA. It blocks the action of DNA polymerases thereby inhibiting viral replication. It has a stronger antiviral effect against the varicella-zoster virus than reference compounds such as aciclovir or penciclovir[1]. It has high, selective activity against varicella zoster virus (VZV), inhibiting VZV replication, possibly through competitive inhibition of viral DNA polymerase, or by acting as an alternative substrate to deoxythymidine triphosphate, causing viral DNA strand breakage[2]. |
| In vivo | At a dose of 125 mg once daily, brivudine has been shown to be superior to aciclovir with respect to reducing the period of new blister production and shortening the duration of post-herpetic neuralgia[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 50 mg/mL (150.09 mM), Sonication is recommended. |
| Keywords | VZV | Inhibitor | inhibit | HSV-1 | Cytomegalovirus | CMV | Brivudine |
| Inhibitors Related | Floxuridine | Docusate sodium | Octyl gallate | 1-Docosanol | Oxytetracycline Hydrochloride | S-Methylisothiourea sulfate | Adenosine 5'-monophosphate monohydrate | Oxyresveratrol | Idoxuridine | Cytarabine | Acyclovir | Ganciclovir |
| Related Compound Libraries | Bioactive Compound Library | Approved Drug Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Anti-Viral Compound Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Preclinical Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $55.00/50mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-16 | |
| $55.00/50mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-07-15 | |
| $0.00/25KG |
VIP6Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2024-09-25 | |
| $780.00/5g |
VIP2Y
|
R&D Scientific Inc.
|
2024-04-26 | |
| $0.00/1kg |
VIP3Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2023-07-13 | |
| $100.00/1KG |
Shijiazhuang Gantuo Biotechnology Co., Ltd
|
2023-03-10 | ||
| $200.00/10g |
Hebei Best Biological Technology Co., Ltd
|
2022-11-30 | ||
| $200.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-11-23 | ||
| $0.00/1kg |
VIP3Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-29 | |
| $1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-07-15 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY